Our top pick for
Building a portfolio

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Centogene N.V is a diagnostics & research business based in the US. Centogene N-V shares (CNTG) are listed on the NASDAQ and all prices are listed in US Dollars. Centogene N-V employs 440 staff and has a market cap (total outstanding shares value) of USD$280.3 million.
Our top pick for
Building a portfolio
Our top pick for
Beginners
Our top pick for
Active traders
52-week range | USD$9.25 - USD$27.1 |
---|---|
50-day moving average | USD$12.0503 |
200-day moving average | USD$11.4784 |
Wall St. target price | USD$20.96 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | USD$-1.0532 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Gross profit TTM | USD$22.8 million |
---|---|
Return on assets TTM | -16.34% |
Return on equity TTM | -84.37% |
Profit margin | -40.7% |
Book value | N/A |
Market capitalisation | USD$280.3 million |
TTM: trailing 12 months
There are currently 208,067 Centogene N-V shares held short by investors – that's known as Centogene N-V's "short interest". This figure is 20.5% up from 172,684 last month.
There are a few different ways that this level of interest in shorting Centogene N-V shares can be evaluated.
Centogene N-V's "short interest ratio" (SIR) is the quantity of Centogene N-V shares currently shorted divided by the average quantity of Centogene N-V shares traded daily (recently around 90858.951965065). Centogene N-V's SIR currently stands at 2.29. In other words for every 100,000 Centogene N-V shares traded daily on the market, roughly 2290 shares are currently held short.
However Centogene N-V's short interest can also be evaluated against the total number of Centogene N-V shares, or, against the total number of tradable Centogene N-V shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Centogene N-V's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Centogene N-V shares in existence, roughly 10 shares are currently held short) or 0.0344% of the tradable shares (for every 100,000 tradable Centogene N-V shares, roughly 34 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Centogene N-V.
Find out more about how you can short Centogene N-V stock.
We're not expecting Centogene N-V to pay a dividend over the next 12 months.
Centogene N. V. , together with its subsidiaries, engages in diagnosis and research around rare diseases that transform clinical and genetic data into information for patients, physicians, and pharmaceutical companies. Its platform analyzes epidemiologic, phenotypic, and genetic data to enhance the understanding of rare hereditary diseases. The company operates through two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment provides various services, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The Diagnostics segment provides genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors.
Steps to owning and managing SGLB, with 24-hour and historical pricing before you buy.
Steps to owning and managing SSD, with 24-hour and historical pricing before you buy.
Steps to owning and managing SQNS, with 24-hour and historical pricing before you buy.
Steps to owning and managing SFL, with 24-hour and historical pricing before you buy.
Steps to owning and managing AIHS, with 24-hour and historical pricing before you buy.
Steps to owning and managing ST, with 24-hour and historical pricing before you buy.
Steps to owning and managing SLCT, with 24-hour and historical pricing before you buy.
Steps to owning and managing EYES, with 24-hour and historical pricing before you buy.
Steps to owning and managing SBSW, with 24-hour and historical pricing before you buy.
Steps to owning and managing SHG, with 24-hour and historical pricing before you buy.